Home  /  Resource Library  /  Clinical and infusion product characteristics influencing the outcomes and toxicity of CAR T-cell treatment with axicabtagene ciloleucel for LBCL

Clinical and infusion product characteristics influencing the outcomes and toxicity of CAR T-cell treatment with axicabtagene ciloleucel for LBCL

Article reviews factors which may effect safety and outcomes of treatment with CAR T therapy axicabtagene ciloleucel.